Navigation Links
Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
Date:7/1/2009

ROCKVILLE, Maryland, July 1 /PRNewswire-USNewswire/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it expects to have top-line results available on Monday, July 20, from BLISS-52, the first of two pivotal Phase 3 clinical trials of BENLYSTA(TM) (belimumab, formerly LymphoStat-B(R)) in systemic lupus erythematosus (SLE).

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

Senior management will host a conference call to discuss the results on Monday, July 20, 2009 at 8:15 AM Eastern. The BLISS-52 data will be submitted for full presentation at an appropriate scientific meeting.

Investors may listen to the call by dialing 888-632-5010 or 913-312-0402, passcode 8364417, five to 10 minutes before the start of the call. A replay of the conference call will be available within a few hours after the call ends. Investors may listen to the replay by dialing 888-203-1112 or 719-457-0820, confirmation code 8364417.

This conference call also will be webcast and may be accessed at www.hgsi.com. Investors interested in listening to the live webcast should log on before the conference call begins in order to download any software required. The archive of the conference call will remain available for several days.

The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs.

HGS, Human Genome Sciences, BENLYSTA and LymphoStat-B are trademarks of Human Genome Sciences, Inc.

Safe Harbor Statement

This announcement contain
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PROLOR Biotech Awarded Two U.S. Patents for Its Longer-Acting Human Growth Hormone and Longer-Acting Erythropoietin
2. Fruit fly steps in to fight human disease
3. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Piper Jaffray Conference
4. Human Genome Sciences Announces Completion of Enrollment in Phase 2b Monthly-Dosing Trial of Albuferon(R)
5. Assessment of safety and efficacy of human embryonic stem cell therapy
6. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
7. Printing New Organs: Foundation Funds Medical Technology That Replicates Human Tissue
8. New MIT radio chip mimics human ear
9. deCODE Study Shows Complex Interplay of the Human Biological Clock With Height, Weight and Disease
10. Human Genome Sciences and Novozymes Announce Amendment to Albumin Fusion License Agreement
11. Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)..., AUSTIN, Texas, Nov. 5 SpineSmi...enOsteo, Inc. to co-develop a unique scaffold that... Following evaluation of several commercial produc...ment, the company believes the GenOsteo scaffold r...that creates a unique and ideal environment for th...
(Date:11/5/2009)... Brooke Sanders brings a ne...ine, CA (PRWEB) November 5, 2009 -- Professional R...g reprographics company is pleased to present Broo...y as their graphics/PR specialist. The addition of...nsistent growth within Professional Reprographics....
(Date:11/4/2009)..., PETERSBURG, Va., Nov. 4 /PRNewswire-FirstCall/...ounced today that the company plans to introduce t...s subsidiary, Rock Creek Pharmaceuticals, for worl...Ventiv Health, Inc . (Nasdaq: VTIV). inVentiv He...solutions for every stage of the product lifecycle...
(Date:11/4/2009)..., ,, NORRISTOWN, Pa., Nov. 4 /PRNewswire/...eutical solutions company, today announced that it...earch , a contract research organization that spe...s, to further extend its business development capa...expertise of industry veteran Robert Westbrook, CE...
Breaking Biology Technology:SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 2Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 3Star Scientific Plans Worldwide Marketing and Sales of CigRx(TM) Nutraceutical in Partnership with inVentiv Health 4Emerson Resources Forges Strategic Partnership with Bio Research 2
...Brings More Than Two Decades of Pharmaceutical, R...ATI, Feb. 1 Kendle (Nasdaq: KNDL ), a,leading, g... today,announced the hiring of Satish Tripathi, Ph...ality. Dr. Tripathi will provide additional leader...he multi-functional global,regulatory group consis...
.... today,announced it anticipates receiving up to $...inancing was led by Alta Partners and Clarus Ventu...cluding Sanderling Ventures, Tango,and High Countr...nly an infusion of capital but the,addition of two...arus,Ventures, represented on our Board respective...
...q: VRUS ) management will be presenting at the BI...ebruary 11 - 13, 2008 at the,Waldorf-Astoria Hotel...ef,Executive Officer, will provide an overview of ... (ET) in the Waldorf-Astoria,s Astor Salon. In,add...ical Officer, will,participate in a hepatitis C vi...
Other Biology Technology:Kendle Hires Satish Tripathi, PhD, RAC as Vice President, Global Regulatory and Quality 2Taligen Therapeutics Secures Series B Financing 2Pharmasset to Present at the BIO CEO & Investor Conference 2008 on Monday, February 11th 2
(Date:11/3/2009)...r of the ocean, cruising thousands of miles in a s...ered that the sharks have maintained such a consis...nds of years the white sharks in the northeastern ...ulation genetically distinct from sharks elsewhere...ly mobile species," said Salvador Jorgensen, a pos...
(Date:11/3/2009)...it and vegetables is a new, patented technology in...sed to label, or "etch" information on produce, th... labels. The technology has been licensed for use ... used in New Zealand, Australia, and Pacific Rim c... Africa, Central and South America, Canada, and th...
(Date:11/3/2009)...executives in 35 of the top Fortune 500 companies ...ries" in 2008, according to a new type of theoreti...rcher to determine fair CEO compensation. , "One...nance issues of the day is how to determine fair p...ian, a professor of chemical engineering. "The pro...
Breaking Biology News(10 mins):Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 2Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 3Tags reveal white sharks have neighborhoods in the north Pacific, say Stanford researchers 4Laser etching safe alternative for labeling grapefruit 2New theory on fairness in economics targets CEO pay 2New theory on fairness in economics targets CEO pay 3New theory on fairness in economics targets CEO pay 4Policy transparency key to saving worlds fisheries 8955 1Policy transparency key to saving worlds fisheries 8955 2Policy transparency key to saving worlds fisheries 8955 3Policy transparency key to saving worlds fisheries 8955 4Policy transparency key to saving worlds fisheries 8955 5CetylMax 28R 29 and Flexadren 28R 29 Win Federal Lawsuit Court Rules Against Imagenetix 49696 1CetylMax 28R 29 and Flexadren 28R 29 Win Federal Lawsuit Court Rules Against Imagenetix 49696 2CetylMax 28R 29 and Flexadren 28R 29 Win Federal Lawsuit Court Rules Against Imagenetix 49696 3Dr Juan Carlos Cobo Newly Elected Chair of the Mutual Protection Trust Board of Trustees 49694 1Dr Juan Carlos Cobo Newly Elected Chair of the Mutual Protection Trust Board of Trustees 49694 2
...y that the Human Genome Project missed 99 percent ...didn,t sequence genes belonging to the vast commun... , Now a $1.45 million grant from the W.M. Keck F... will help fill this gap by funding a study to dev...analyzing the genomes of "friendly" bacteria that ...
...ublished in the journal Blood, Yale scientists ide...ous T Cell Lymphoma (CTCL) cells to clonally expan... , CTCL is the most common adult malignancy of T ...ystem. Finding CTCL triggering factors has been a ...f the Yale Cancer Center, and professor and chair ...
...understanding the evolution of life on Earth may b...elow the ocean floor, say scientists at the Univer...entists are making new contributions to this field...mal fluid discharge into the Earth,s oceans, which...rmed four billion years ago. Conditions below the ...
Other Biology News:W.M. Keck Foundation funds study of friendly microbes 2W.M. Keck Foundation funds study of friendly microbes 3Source of molecular triggers in cutaneous T cell lymphoma identified 2UCSB scientists probe sea floor venting to gain understanding of early life on Earth 2UCSB scientists probe sea floor venting to gain understanding of early life on Earth 3
...for the detection of inorganic phosphate. This pro...sphate-binding protein labeled with the fluorophor...onment.How it worksBinding of inorganic phosphate ...), resulting in a large increase in fluorescence. ...
...s a unique product that facilitates the easy remov...is CLS number is a new product number, created to ...o availability yet, please order under the old Sig...service for assistance. ID clarifier: 96-well stri...
Distillation Hood from Terra Universal, Inc.
Endotoxin Gel formation Assay Kit, E-TOXATE from Sigma-Aldrich
Biology Products: